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European Health Economics, Stockholm, Sweden
OBJECTIVE: In osteoporosis the bone mass is decreased,
thereby increasing the risk of fractures. Common osteoporotic
fractures include those at the hip, spine and forearm. Fractures
are a burden to the society; both in terms of costs, morbidity and
mortality. The main objective of this study was to investigate
some important aspects of the burden of osteoporosis in Sweden
in a health economic perspective. METHODS: The study used a
combinated incidence/prevalence bottom-up approach to esti-
mate the total annual burden of osteoporosis in Sweden. The
burden was assessed in a societal perspective including medical
care costs, non-medical care costs, informal care and indirect
costs. Moreover, the value of quality-adjusted life-years (QALYs)
foregone because of fractures was included in the total burden
estimations. RESULTS: The total annual fracture cost was esti-
mated at MSEK 6547, which is about 3.2% of the total health
care costs in Sweden. Community care was the most important
cost category accounting for 66% of the total annual cost fol-
lowed by medical care costs (31%), informal care (2%) and indi-
rect costs (1%). By combining the annual value of QALYs
foregone (MSEK 10,354) and the annual fracture costs the total
annual societal burden of osteoporosis in Sweden was estimated
at MSEK 16,901. Assuming no changes in the age-differentiated
fracture risk the burden of osteoporosis was projected to increase
to MSEK 26,301 in year 2050. CONCLUSIONS: This study
shows that the societal burden of osteoporosis in Sweden is
higher than previously perceived. The burden of osteoporosis is
substantial and has to be acknowledged as an important health
problem. Osteoporosis related fractures do not only lead to high
medical care costs but also lead to high community care costs.
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OBJECTIVES: The aim of the study is to compare the burden
of displaced and undisplaced medial femoral neck fracture
treated with primary osteosynthesis in patients under 60 years
on 2 years follow up. METHODS: Data derive from the ﬁnan-
cial database of the National Health Insurance Fund Adminis-
tration and based on the S7200 code (femoral neck fracture) of
the International Classiﬁcation of Diseases (ICD) tenth revision
and the surgical codes of the Hungarian Homogenous Disease
Groups related to primary treatment of fracture in 2000. The
patients with polytrauma were excluded from the study. During
the 2 years follow up we analysed the health insurance costs,
ratio of further treatments, the ratio of multiple treatment and
mortality, while during the 3 years follow up we analysed the
50–100% impaired ability to work. The health insurance costs
include the reimbursement of acute and chronic inpatient care,
outpatient care and sick-pay costs. Exchange rate: 1 EUR =
253,23 HUF. RESULTS: Altogether 413 patients were included
into the study, 154 undisplaced and 259 displaced femoral neck
fracture. Undisplaced fracture: average cost per patient 1993
EUR for all the patients, 3682 EUR for patients with complica-
tions. The ratio of further treatment is 12.9% (secondary pros-
thesis 6.5%), ratio of multiple treatment 2.6%. Ratio of patients
with impaired ability to work was 21.4% on average. Displaced
fracture: average cost per patient 2249 EUR for all the patients,
4074 EUR for patients with complications. The ratio of further
treatment is 21.6% (secondary prosthesis 12.4%), ratio of mul-
tiple treatment 4.6%. Ratio of patients with impaired ability to
work was 25.1% on average. CONCLUSION: In case of using
osteosynthesis after displaced femoral neck fracture, the ratio of
further treatment (secondary prosthesis and multiple treat-
ments), impaired patients and the costs are signiﬁcantly higher.
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OBJECTIVES: The national health insurance database covers
97% of the population in Hungary. The aim of our study was
to assess the osteoporosis related health care utilisation and
disease management in Hungary, focussing on hip fractures and
on the activity of the qualyﬁed Osteoporosis Centre (OPC)
network. METHODS: A systematic search was performed in the
database between 1999–2003. Patients of age 50–100 with frac-
tures and/or osteoporosis were identiﬁed. Reports on visits to
OPCs, osteodensitometries were analysed by age and gender.
RESULTS: Hip fractures increased consistently (women:
8570–9180, men 2200–3480) leading to mean 556,800/40,450
acute, and 3652/1129 chronic bed days/year, respectively. A total
of 67,600 women (115,860 cases) and 5980 men (9010 cases)
visited an OPC in 1999; while 151,340 (261,550) and 13,300
(19,770) in 2003. A total 345,060 women and 36,130 men had
osteoporosis diagnosis in an OPC during the 5 years, 49% and
45% of them was 50–65 years age. A total 94–98% of the
patients had osteodensitometry in the year of the diagnosis.
47.1%, 37.9% and 38.1% of women with hip, forearm or shoul-
der fracture did not have osteoprosis diagnosis during the 5 years
(men: 89.1%, 88.6%, 88.8%). Osteodensitometry was per-
formed in 5%, 13% and 11.6% of women with hip, forearm or
shoulder fracture in 1999, slightly higher rates occurred in 2002
(6.9%, 18.8% and 16%); lower proportions were observed in
males (2.2–2.9%) and 3–5% of the patients had osteoporosis
diagnosis. CONCLUSIONS: Hip fracture has a signiﬁcant
burden on the health care system in Hungary. Osteoporosis
related health care utilisation increased consistently in the time
period observed. However, the rate of patients screened for
osteoporosis before fracture was rather low and patient ways for
osteporosis management after fracture were not guaranteed. Our
study provide helpful data for further target population identiﬁ-
cation and health care improvement projects.
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OBJECTIVES: Osteoporosis affects a 35% of the Spanish
women over 50. This percentage rises to 52% in those who are
over 70. Currently, bisphosphonates (alendronate, etidronate
and risedronate) and raloxifene are approved by the Spanish
Agency of Medicines and Health care Products for preventing
